Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease

Annals of Clinical Biochemistry

Volumn 46, Issue 5, 2009, Pages 368-372

  Bando, Yukihiro ^a   Kanehara, Hideo ^a   Toya, Daisyu ^a   Tanaka, Nobuyoshi ^a   Kasayama, Soji ^b   Koga, Masafumi ^c  

^a FUKUI KEN SAISEIKAI HOSPITAL   (Japan)

^b Nissay Hospital   (Japan)

^c Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; CHOLINESTERASE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOCYTE COUNT;

AGED; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 69749114550     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.008231     Document Type: Article

References (23)

1. Cohen MP. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy? J Diabetes Complications 1998;2:214-217
2. 1c in diabetes mellitus. N Engl J Med 1976;295:417-420
3. Bunn HF, Gabbay KH, Gallop PM. The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 1978;20:21-27
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
5. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabetes Med 2004;21:657-665 (Pubitemid 38916208)
6. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153-163 (Pubitemid 32142912)
7. Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glycosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979;76:4258-4261 (Pubitemid 9256541)
8. Takei I. Glycoalbumin. Lab Clin Pract 2003;21:80-84 (Japanese)
9. Subhiyah BW, AI-Hindawi AY. Red cell survival and splenic accumulation of radiochromium in liver cirrhosis with splenomegaly. Br J Haematol 1967;13:773-778
10. Cacciatore L, Cozzolino G, Giardina MG, et al. Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 1988;7:185-188 (Pubitemid 18154825)
11. 1 in cirrhosis of the liver. Diabetes Res 1989;11:177-180
12. Trenti T, Cristani A, Cioni G, Pentore R, Mussini C, Ventura E. Fructosamine and glycated hemoglobin as indices of glycemic control in patiente with liver cirrhosis. Res Clin Lab 1990;20:261-267
13. Bianchi R, Miriani G, Pilo A, Toni MG. Serum albumin turnover in liver cirrhosis. J Nucl Biol Med 1974;18:20-29
14. Stefanovic S, Bosnjakovic V, Stajnfl S, Vujnic V, Petric J, Ristic M. Characteristics of albumin turnover in different stages of cirrhosis of liver evaluated by means of radioisotope technique and analog computer analysis. Radiobiol Radiother 1972;13:105-111
15. Watanabe A, Matsuzaki S, Moriwaki H, Suzuki K, Nishiguchi S. Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics. Nutrition 2004;20:351-357 (Pubitemid 38388508)
16. Bando Y, Tachibana Y, Fukuoka K, Toy T, Tanaka N, Yanagi S. Clinical study of long-term glycemic control makers in patients with chronic liver disease. J Japan Diab Soc 1997;40:17-24
17. Sherlock S. The portal venous system and portal hypertension. In: Sherlock S, Dooley J eds. Disease of the Liver and Biliary System, Oxford: Blackwell Science, 1993;132-178
18. Koga M, Matsumoto S, Saito H, Kasayama S. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients. Endocrine J 2006;53:387-391 (Pubitemid 43988169)
19. 1c. Diabetes Care 2002;25:275-278
20. Shima K, Ito N, Abe F, et al. High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 1988;31:627-631 (Pubitemid 18213440)
21. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chem Acta 2007;378:48-52 (Pubitemid 46241059)
22. 1C) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocrine J 2007;54:139-144
23. 1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008;81:258-262